The American Association for Thoracic Surgery (AATS) and the Cardiovascular Research Foundation (CRF) have announced a strategic partnership for CRF’s New York Valves 2024: The Structural Heart Summit (5–7 June, New York, USA), making AATS the cardiothoracic surgical society partner of the meeting.
New York Valves is the expanded iteration of CRF’s annual Transcatheter Valve Therapy (TVT) conference.
Under this new partnership, AATS and CRF will collaborate on the development of the New York Valves 2024 programme. AATS leaders, David Adams (Icahn School of Medicine at Mount Sinai, New York, USA) and Lars G Svensson (Cleveland Clinic, Cleveland, USA) have been appointed to the programme executive committee with a charge to ensure advances in surgical approaches and techniques in valve disease is a major focus of New York Valves going forward.
“We’re honoured to partner with AATS on CRF’s new and expanded New York Valves summit which redefines innovation and multidisciplinary collaboration in structural heart care,” said Martin B Leon, founder and chairman emeritus of CRF and New York Valves programme director. “It’s an incredible opportunity to collaborate closely with the world’s leading experts in thoracic and cardiovascular surgery. At the heart of advancing structural heart care lies multidisciplinary collaboration, where the active engagement of interventional cardiologists, cardiac surgeons, clinical cardiologists, cardiac imagers, and heart failure experts is paramount. We aim to leverage the combined expertise of all specialties to develop personalised treatment approaches for patients with valvular and structural heart disease.”
“As two of the leading groups dedicated to advancing the field of cardiovascular education, the partnership between AATS and CRF will make New York Valves a comprehensive educational event like no other,” said Adams. “I am excited to see colleagues from the entire Heart Team come together as we gather for what is certain to be a globally impactful annual meeting in the capital city of the world. We have had world-class meetings focusing primarily on transcatheter valve intervention or surgery, but now we envision the ultimate Heart Team meeting where we will debate, discuss, and move forward together.”
“Technology in our field is changing rapidly, impacting and evolving our patient care on a daily basis,” said Svensson. “This new partnership gives New York Valves access to the world’s leading cardiac surgeons, and through our work together, we can improve quality of patient care while developing deeper understanding of structural heart diseases and disorders.”
“This partnership epitomises the spirit of multidisciplinary collaboration in advancing structural heart care,” said Juan Granada, president and chief executive officer of CRF and New York Valves programme director. “CRF has a long-standing commitment to driving progress in the field and nurturing future generations of cardiovascular specialists. New York Valves presents an ideal platform to harness the collective expertise of the Heart Team, fostering innovation and enhancing patient outcomes.”
“Through this new partnership, we can safely say there is no greater opportunity for the global Heart Team to focus on valvular heart disease, aortic stenosis, myocarditis, the complex heart conditions that challenge us today and tomorrow,” said David R Bobbitt, chief executive officer of AATS.
